Shares of Elite Pharmaceuticals Inc. (OTCMKTS:ELTP - Get Free Report) gapped up prior to trading on Friday . The stock had previously closed at $0.73, but opened at $0.76. Elite Pharmaceuticals shares last traded at $0.72, with a volume of 176,436 shares changing hands.
Elite Pharmaceuticals Stock Up 2.9%
The company has a quick ratio of 1.90, a current ratio of 3.27 and a debt-to-equity ratio of 0.12. The stock's 50-day simple moving average is $0.55 and its 200 day simple moving average is $0.50. The firm has a market cap of $782.04 million, a P/E ratio of -36.60 and a beta of 0.16.
Elite Pharmaceuticals (OTCMKTS:ELTP - Get Free Report) last announced its earnings results on Monday, June 30th. The specialty pharmaceutical company reported $0.01 EPS for the quarter. Elite Pharmaceuticals had a negative return on equity of 6.92% and a negative net margin of 25.70%.
Elite Pharmaceuticals Company Profile
(
Get Free Report)
Elite Pharmaceuticals, Inc, a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals. The company operates in two segments, Abbreviated New Drug Applications for Generic Pharmaceuticals and New Drug Applications for Branded Pharmaceuticals.
Featured Stories
Before you consider Elite Pharmaceuticals, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Elite Pharmaceuticals wasn't on the list.
While Elite Pharmaceuticals currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
